WallStreetZenWallStreetZen

NASDAQ: FENC
Fennec Pharmaceuticals Inc Earnings & Revenue

OverviewForecastEarnings
DividendOwnership

FENC past revenue growth

How has FENC's revenue growth performed historically?
Company
1,284.5%
Industry
148.97%
Market
17.57%
FENC's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
FENC's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
FENC's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

FENC earnings and revenue history

Current Revenue
$21.3M
Current Earnings
-$16.0M
Current Profit Margin
-75.5%

FENC Return on Equity

Current Company
N/A
Current Industry
-63.5%
Current Market
188%

Be the first to know when FENC announces earnings.

FENC Return on Assets

Current Company
-73.6%
Current Industry
2.9%
FENC is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

FENC Return on Capital Employed

Current Company
-65.51%
Current Industry
19.5%
FENC's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

FENC vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
FENC$21.25M-$12.65M-$16.05M+498.68%N/A
TSVT$100.39M-$207.29M-$217.57M+12.96%N/A
VTYX$0.00-$192.02M-$192.96MN/AN/A
INO$832.01k-$130.39M-$135.12M-51.33%N/A
IMMP$4.40MN/A-$26.47M+4.12%N/A
View Top Biotech Stocks

FENC earnings dates

Next earnings date
May 9, 2024

Fennec Pharmaceuticals Earnings & Revenue FAQ

What were FENC's earnings last quarter?

On Invalid Date, Fennec Pharmaceuticals (NASDAQ: FENC) reported Q4 2023 earnings per share (EPS) of -$0.10, up 60% year over year. Total Fennec Pharmaceuticals earnings for the quarter were -$2.68 million. In the same quarter last year, Fennec Pharmaceuticals's earnings per share (EPS) was -$0.25.

If you're new to stock investing, here's how to buy Fennec Pharmaceuticals stock.

What was FENC's earnings growth in the past year?

As of Q2 2024, Fennec Pharmaceuticals's earnings has grown year over year. Fennec Pharmaceuticals's earnings in the past year totalled -$16.05 million.

What is FENC's earnings date?

Fennec Pharmaceuticals's earnings date is Invalid Date. Add FENC to your watchlist to be reminded of FENC's next earnings announcement.

What was FENC's revenue last quarter?

On Invalid Date, Fennec Pharmaceuticals (NASDAQ: FENC) reported Q4 2023 revenue of $9.74 million up 534.2% year over year. In the same quarter last year, Fennec Pharmaceuticals's revenue was $1.54 million.

What was FENC's revenue growth in the past year?

As of Q2 2024, Fennec Pharmaceuticals's revenue has grown 1,284.5% year over year. This is 1,135.52 percentage points higher than the US Biotechnology industry revenue growth rate of 148.97%. Fennec Pharmaceuticals's revenue in the past year totalled $21.25 million.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.